Elanco Animal Health released its earnings results on May 09, 2023. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.285 by $0.165.

Is Elanco Animal Health overvalued?

According to Wall Street analysts Elanco Animal Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Elanco Animal Health pay dividends?

Elanco Animal Health does not currently pay dividends.

What is Elanco Animal Health’s EPS estimate?

Elanco Animal Health’s EPS estimate is $0.06.

How many shares outstanding does Elanco Animal Health have?

Elanco Animal Health has 492,550,480 shares outstanding.

What happened to Elanco Animal Health’s price movement after its last earnings report?

Elanco Animal Health reported an EPS of $0.45 in its last earnings report, beating expectations of $0.285. Following the earnings report the stock price went down -0.534%.

Which hedge fund is a major shareholder of Elanco Animal Health?

Among the largest hedge funds holding Elanco Animal Health’s share is Dodge & Cox. It holds Elanco Animal Health’s shares valued at 797M.

---

Elanco Animal Health Stock Smart Score

Neutral

Fundamentals

Return on Equity

-0.29%

Trailing 12-Months

Asset Growth

-2.97%

Trailing 12-Months

The Elanco Animal Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Learn more about TipRanks Smart Score

Go to Top Smart score Stocks >

Company Description

Elanco Animal Health

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.

---